SNCA and Parkinson disease: Parkinson’s disease (PD), the second most common neurodegenerative disease, is characterized by motor symptoms, including bradykinesia with tremor and/or muscle rigidity, and histologic changes, including the accumulation of Lewy bodies predominantly composed of α-synuclein and the pathologic loss of dopaminergic neurons in substantia nigra [1].